| |||||||
| |||||||
| |||||||
| 1 | HOUSE RESOLUTION
| ||||||
| 2 | WHEREAS, The Department of Health and Human Services (HHS) | ||||||
| 3 | has announced proposed changes to the federal regulations | ||||||
| 4 | governing the confidentiality of patient records created by | ||||||
| 5 | federally-assisted substance use disorder treatment programs, | ||||||
| 6 | known as 42 CFR part 2; and
| ||||||
| 7 | WHEREAS, The 42 CFR part 2 regulations serve to protect | ||||||
| 8 | patient records created by federally-funded programs for the | ||||||
| 9 | treatment of substance abuse disorder (SUD); SAMHSA is | ||||||
| 10 | currently proposing to revise part 2 to facilitate better | ||||||
| 11 | coordination of care for substance use disorders, which will | ||||||
| 12 | also enhance care for opioid use disorder (OUD); these | ||||||
| 13 | provisions will be an important part of the Federal response to | ||||||
| 14 | the opioid epidemic, while maintaining part 2 confidentiality | ||||||
| 15 | protections; and
| ||||||
| 16 | WHEREAS, In these proposed federal regulation changes, | ||||||
| 17 | "non-OTP (opioid treatment program) providers will become | ||||||
| 18 | eligible to query a central registry, in order to determine | ||||||
| 19 | whether their patients are already receiving opioid treatment | ||||||
| 20 | through a member program," and "OTPs will be permitted to | ||||||
| 21 | enroll in a state prescription drug monitoring program (PDMP), | ||||||
| 22 | and permitted to report data into the PDMP when prescribing or | ||||||
| 23 | dispensing medications on Schedules II to V, consistent with | ||||||
| |||||||
| |||||||
| 1 | applicable state law"; and
| ||||||
| 2 | WHEREAS, These changes could improve the care of persons | ||||||
| 3 | with opioid use disorder because primary care providers could | ||||||
| 4 | more easily receive treatment information from other treatment | ||||||
| 5 | programs and could utilize the Illinois Prescription Drug | ||||||
| 6 | Monitoring Program to see if a patient is receiving methadone | ||||||
| 7 | or other controlled substances from an opioid treatment program | ||||||
| 8 | (OTP); these changes will help to prevent duplicative | ||||||
| 9 | enrollments in SUD care, duplicative prescriptions in SUD | ||||||
| 10 | treatment, and adverse drug events related to SUD treatment; | ||||||
| 11 | and
| ||||||
| 12 | WHEREAS, The proposed rule will not alter the basic | ||||||
| 13 | framework for confidentiality protection of SUD patient | ||||||
| 14 | records created by federally-funded treatment programs; part 2 | ||||||
| 15 | will continue to prohibit law enforcement use of SUD patient | ||||||
| 16 | records in criminal prosecution against the patient; part 2 | ||||||
| 17 | will also continue to restrict the disclosure of SUD treatment | ||||||
| 18 | records without patient consent, other than as statutorily | ||||||
| 19 | authorized in the context of a bona fide medical emergency, or | ||||||
| 20 | for the purpose of scientific research, audit, or program | ||||||
| 21 | evaluation, or based on an appropriate court order for good | ||||||
| 22 | cause; therefore, be it
| ||||||
| 23 | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE | ||||||
| |||||||
| |||||||
| 1 | HUNDRED FIRST GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that | ||||||
| 2 | we urge the support of the proposed changes to 42 CFR part 2 to | ||||||
| 3 | improve communication and exchange of information between all | ||||||
| 4 | providers of care for people with substance abuse disorder; and | ||||||
| 5 | be it further
| ||||||
| 6 | RESOLVED, That suitable copies of this resolution be | ||||||
| 7 | presented to the members of the Illinois Congressional | ||||||
| 8 | Delegation.
| ||||||